[-] Show simple item record

dc.contributor.authorWang, Sijieeng
dc.date.issued2018-04eng
dc.description.abstractOpioid medications are an underappreciated cause of serotonin syndrome. Fentanyl, meperidine, and methadone are more commonly associated with this potentially life-threatening side effect. Here, we present the case of a 60-year-old man taking duloxetine, oxycodone as needed, and long-acting hydromorphone for chronic pain, who developed serotonin syndrome two days after his hydromorphone dose was increased. Due to severe agitation he required intubation and his course was notable for marked adrenergic instability. Eventually, he improved after treatment with benzodiazepines and cyproheptadine. This case highlights a rare synergistic effect from the combination of hydromorphone, duloxetine, and oxycodone resulting in serotonin syndrome.eng
dc.description.bibrefIncludes bibliographical referenceseng
dc.format.extent4 pageseng
dc.identifier.citationAm J Hosp Med 2018 Apr;2(2):2018.010 https://doi.org/10.24150/ajhm/2018.010eng
dc.identifier.urihttps://hdl.handle.net/10355/63844
dc.identifier.urihttps://doi.org/10.24150/ajhm/2018.010eng
dc.languageEnglisheng
dc.publisherUniversity of Missouri, Department of Medicine, Division of Hospital Medicineeng
dc.relation.ispartofAmerican journal of hospital medicine, volume 2, issue 2 (2018 April-June)eng
dc.relation.ispartofseriesCase report (AJMH)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
dc.sourceHarvested from the American Journal of Hospital Medicine website (http://medicine2.missouri.edu/jahm/) in 2018.eng
dc.titleHydromorphone precipitating serotonin syndromeeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record